TG Therapeutics Inc (NASDAQ:TGTX)

During the Trading Day
14.85 +0.72 / +5.10%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
15.47 +0.62 / +4.18%
 
Volume: 7.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

--
Revenue and IncomeNet Revenues0.0019.0K152.4K--
 
 
 
Depreciation And Amortization0.00235.001.1K--
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses882.0K25.8M20.3M--
 
 
 
 
Research And Development327.3K21.0M13.7M--
 
 
 
 
Total Operating Expenses882.0K25.8M20.3M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-882.0K-25.8M-20.2M--
 
 
 
 
Extraordinary Credit0.001.7M3.3M--
 
 
 
Extraordinary Charge0.00-1.1M-2.8M--
 
 
 
Interest Expense On Debt7.1K905.7K952.9K--
 
 
 
 
Other Expenses0.00272.2K108.9K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-889.1K-25.9M-20.5M--
 
 
 
 
Income Taxes0.00-330.0K0.00--
 
 
Minority Interest-36.0K-8.1M0.00--
 
 
 
Net Income-853.1K-18.1M-20.5M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2K13.1M25.4M--
 
 
 
 
Shares To Calculate EPS Diluted34.2K13.1M25.4M--
 
 
 
 
 
Earnings Per ShareEPS-$24.75-$1.38-$0.81--
 
 
 
 
EPS Diluted-$24.75-$1.38-$0.81--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account